CME to Launch SEC-Registered Clearing House to Expand Treasury Clearing Capacity
Sep 10, 2026, 11:37 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
The addition of a new SEC-registered clearing house alongside existing cross-margining likely lowers costs for participants, improves liquidity, and could attract more clearing volume, supporting CME’s clearing revenue and overall stock value as the regulatory deadlines approach.
AI summary
What happened, with direct paths to the underlying reporting
CME Group will launch CME Securities Clearing Inc. on December 7, 2026, pending regulatory approvals, to provide a capital-efficient clearing option for U.S. Treasury cash and repo transactions. The new SEC-registered clearing agency will coexist with CME's cross-margining with FICC, potentially lowering margins and expanding clearing capacity as deadlines approach, which could bolster CME Clearing’s revenue and market share.
CME Group to launch CME Securities Clearing Inc. on December 7, 2026. Pending regulatory approvals.
New SEC-registered clearing house to clear U.S. Treasures cash and repo, capital-efficiently.
Cross-margining with CME Clearing and FICC already saves over $2 billion daily in margin.
Treasury clearing deadlines: cash by 12/31/2026; repo by 6/30/2027.
Expansion could boost CME Clearing revenue and market share through greater capacity and choices.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
CME Group reported a fresh FX futures and options open-interest record of 4.41 million contracts on Sept 4, 2026, with large holders totaling 1,446 and asset managers notional exc…
CME Group will launch Treasury Link, linking CBOT Treasury futures with BrokerTec cash Treasuries in a single spread. The Q4 2026 rollout, pending regulatory approval, could lift…
As regulatory disputes intensify around prediction markets, CME Group's focus on non-sports event contracts may help mitigate risks. The surge in private company valuations indica…